Bayer Norden News
07-Aug-2008
Bayer Acquires Preclinical Anti-cancer Program from Nycomed
Berlin. Bayer Schering Pharma AG, Germany, is expanding its oncology pipeline with the acquisition of a preclinical oncology program from Nycomed, a pharmaceutical company headquartered in Switzerland. The agreement comprises two potential drug candidates and an extensive set of back-up compounds targeting a kinase critical for growth and survival of cancer cells.
Bayer Acquires Preclinical Anti-cancer Program from Nycomed
Berlin. Bayer Schering Pharma AG, Germany, is expanding its oncology pipeline with the acquisition of a preclinical oncology program from Nycomed, a pharmaceutical company headquartered in Switzerland. The agreement comprises two potential drug candidates and an extensive set of back-up compounds targeting a kinase critical for growth and survival of cancer cells.
16-Apr-2008
Medicinal plants receive Bayer’s Innovation Award
Protein made in genetically modified plants can help millions of elderly people under the risk of developing senility. The Danish scientist behind the development is rewarded with Innovation Award from Bayer CropScience.
Medicinal plants receive Bayer’s Innovation Award
Protein made in genetically modified plants can help millions of elderly people under the risk of developing senility. The Danish scientist behind the development is rewarded with Innovation Award from Bayer CropScience.
15-Apr-2008
Healthier feed receives Innovation Award
Bayer CropScience rewards Swedish pig feed strategy with Innovation Award 2008. The new feed has meant both healthier pigs and less environmental impact.
Healthier feed receives Innovation Award
Bayer CropScience rewards Swedish pig feed strategy with Innovation Award 2008. The new feed has meant both healthier pigs and less environmental impact.

Bayer Sports
Bookmark this page
E-mail this page